ArticleClinical and experimental medicine2025
The expression of CD109 in B-cell acute lymphoblastic leukemia and its potential as a promising marker for minimal residual disease (MRD) detection.
Zhifang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.